Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$505M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$443M |
| 3 |
Alibaba
BABA
|
+$370M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$284M |
| 5 |
Procter & Gamble
PG
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$40M |
| 2 |
Home Depot
HD
|
+$38.9M |
| 3 |
JD.com
JD
|
+$35.3M |
| 4 |
SPDR Gold Trust
GLD
|
+$31.6M |
| 5 |
Tesla
TSLA
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 25.83% |
| 2 | Healthcare | 17.87% |
| 3 | Consumer Discretionary | 13.79% |
| 4 | Technology | 4.61% |
| 5 | Financials | 4.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
US Physical Therapy
USPH
$1.22B
| $1.83M | 0.01% |
18,414
+4,297
| +30% | +$410K |
|
702
Lithia Motors
LAD
$8.26B
| $1.82M | 0.01% |
6,062
-809
| -12% | -$253K |
|
703
Ross Stores
ROST
$81.9B
| $1.81M | 0.01% |
20,033
+11,722
| +141% | +$1.12M |
|
704
Fulgent Genetics
FLGT
$527M
| $1.81M | 0.01% |
28,938
+6,929
| +31% | +$456K |
|
705
Western Digital
WDC
$150B
| $1.8M | 0.01% |
+48,050
| New | +$1.97M |
|
706
Commercial Metals
CMC
$8.31B
| $1.8M | 0.01% |
43,173
-14,775
| -25% | -$555K |
|
|
AUY
707
DELISTED
Yamana Gold, Inc.
AUY
| $1.78M | 0.01% |
318,385
+178,803
| +128% | +$845K |
|
|
LAZR
708
DELISTED
Luminar Technologies
LAZR
| $1.78M | 0.01% |
+7,576
| New | +$1.66M |
|
709
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $1.77M | 0.01% |
21,460
| – | – |
|
710
Privia Health
PRVA
$2.87B
| $1.76M | 0.01% |
66,038
+16,616
| +34% | +$392K |
|
711
Avis
CAR
$5.02B
| $1.76M | 0.01% |
6,685
+4,754
| +246% | +$956K |
|
712
Amdocs
DOX
$6.22B
| $1.76M | 0.01% |
21,377
+10,239
| +92% | +$802K |
|
713
BJ's Restaurants
BJRI
$1.48B
| $1.74M | 0.01% |
61,489
+14,554
| +31% | +$443K |
|
714
CBRE Group
CBRE
$42.9B
| $1.73M | 0.01% |
+18,894
| New | +$1.84M |
|
715
Lumen
LUMN
$6.44B
| $1.72M | 0.01% |
152,903
+80,515
| +111% | +$922K |
|
716
Itron
ITRI
$4.54B
| $1.72M | 0.01% |
32,606
+16,215
| +99% | +$907K |
|
717
EPAM Systems
EPAM
$5.03B
| $1.67M | 0.01% |
+5,644
| New | +$2.21M |
|
718
Constellium
CSTM
$3.99B
| $1.66M | 0.01% |
92,266
+22,118
| +32% | +$403K |
|
719
OptimizeRx
OPRX
$133M
| $1.63M | 0.01% |
43,134
+10,434
| +32% | +$462K |
|
|
VIVO
720
DELISTED
Meridian Bioscience Inc
VIVO
| $1.61M | 0.01% |
62,228
+14,330
| +30% | +$341K |
|
721
B2Gold
BTG
$6.64B
| $1.61M | 0.01% |
349,514
+202,796
| +138% | +$815K |
|
|
CVGW
722
DELISTED
Calavo Growers
CVGW
| $1.6M | 0.01% |
44,035
+10,111
| +30% | +$412K |
|
723
Centene
CNC
$32.5B
| $1.6M | 0.01% |
+18,992
| New | +$1.56M |
|
724
MongoDB
MDB
$32.1B
| $1.59M | 0.01% |
+3,593
| New | +$1.4M |
|
725
Essential Utilities
WTRG
$11.4B
| $1.58M | 0.01% |
30,924
+15,817
| +105% | +$763K |
|
Similar funds
Ray Dalio's Q1 2022 Portfolio in Review
As of Q1 2022, Ray Dalio held 991 positions worth $24.8B, up 44% from $17.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ray Dalio deployed $8.89B of net new capital in Q1 2022, opening 260 new positions and adding to 547 existing holdings. Its largest new stake was Medtronic: 1,880,088 shares worth $209M.
By sector, the portfolio is most concentrated in Consumer Staples at 26% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Lowe's Companies, an estimated $40M trimmed.
- Ray Dalio's largest Q1 2022 buy was Medtronic: 1,880,088 shares worth $209M.
- Ray Dalio added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $505M increase.
- Ray Dalio's biggest Q1 2022 reduction was Lowe's Companies, cutting an estimated $40M.
- Ray Dalio fully exited Tesla in Q1 2022, selling an estimated $26.9M.
- Ray Dalio's ten largest holdings make up 34% of its $24.8B portfolio in Q1 2022.
- Ray Dalio opened 260 new positions and closed 23 in Q1 2022.
- Ray Dalio's portfolio value rose 44% quarter-over-quarter to $24.8B.
Based on Bridgewater Associates's 13F filing for Q1 2022, filed 13 May 2022.